COVID19
The Centre has exempted basic Customs duty on the import of specific APIs (active pharmaceutical ingredients) for Black Fungus medicine Amphotericin B and the raw materials used for manufacturing Covid test kits.

Read More

Aravind Natarajan 13 July 2021
With the onset of COVID, the world as we know has changed. One of the biggest fallouts of the ongoing pandemic has been the confusion around how laws need to be enacted, which law would take precedence in a particular situation, what are the local rules and how do they impact our rights as citizens.

Read More

Covid-19 likely contributed to 216.4 million excess doses of antibiotics for adults,

Read More

The Supreme Court on Wednesday said the National Disaster Management Authority (NDMA) is statutorily mandated to provide minimum standards of relief, which should include ex-gratia for those who have succumbed to Covid.

Read More

Moneylife Digital Team 29 June 2021
The announcement pertaining to economic relief for the pandemic announced by the Union government broadly emphasizes four sectors - health, tourism, micro finance institutions (MFIs) and agriculture while the other measures announced fine-tune the scope of the already existing arrangement, says a research note.

Read More

Moneylife Digital Team 25 June 2021
The union government on Friday announced tax exemption for expenditure incurred on COVID treatment and ex-gratia amount received on death. Granting further relief in difficult COVID times, it also extended dates of several compliances.

Read More

The National Anti-Profiteering Authority (NAA) has directed GST officials to ensure that the reduced tax rates on Covid-related items are passed on to the consumers.

Read More

Moneylife Digital Team 22 June 2021
The Bombay High Court on Tuesday took a serious note of the spate of fake coronavirus (COVID) vaccination scams in Mumbai and asked Maharashtra government and the BrihanMumbai Municipal Corp (BMC) to catch the kingpins and unearth the entire racket.

Read More

Moneylife Digital Team 22 June 2021
India's second COVID-19 wave is finally ebbing, with weekly average cases declining to about 60,000. That is still high, but a huge relief nevertheless, when considering that cases had risen to 4.14 lakh just a month back.

Read More

The Supreme Court on Monday asked the Central government, whether the National Disaster Management Authority (NDMA), which is headed by the Prime Minster, has taken any decision not pay Rs 4 lakh compensation to families of those who succumbed to Covid.

Read More

Moneylife Digital Team 19 June 2021
Two months back when the relentless second wave of COVID started, we started seeing people drawn from different walks of life coming together and helping each other out of this adversity.

Read More

In order to ensure the cuts in GST rates of essential Covid-19 drugs and other medications is passed on to consumers, the National Pharmaceutical Pricing Authority has directed all pharma manufacturing and marketing companies to revise the maximum retail price (MRP) on drugs and formulations immediately taking into effect the reduced tax rate.

Read More

Moneylife Digital Team 16 June 2021
Refuting rumours spread by some social media posts about the use of new-born calf serum in Covaxin, the Union government on Wednesday clarified that the coronavirus (COVID) vaccine manufactured by Bharat Biotech Ltd, does not contain new-born calf serum.

Read More

There has been sharp decline in both new and active Covid-19 cases across India for the last few days, the Union Health Ministry said on Tuesday.

Read More

Innumerable RTI activists and users across the country have sought information since April 2020, regarding various issues related to the catastrophic COVID-19 pandemic that directly affects every citizen of this country

Read More

Moneylife Digital Team 11 June 2021
A few weeks back when the country was dealing with the gruesome second wave of the COVID-19 pandemic with hospitals running over-capacity along with massive shortage of health care facilities, medicines and oxygen, many corporates across India pitched in to help in COVID relief efforts.

Read More

The US Food and Drug administration has denied approval for emergency use of Covaxin, developed by Hyderabad-based Bharat Biotech, and has asked for additional data, biopharmaceutical Ocugen, the US partner of the Indian vaccine maker has said.

Read More

As economic activities have slowed down amid the second wave of Covid-19 and lockdowns across states, a Finance Ministry report has said that faster vaccine coverage and frontloading of fiscal measures announced in this year's budget would be the major factors in boosting the investment and consumption cycles and, in turn, reviving the economy.

Read More

Coronil, the so-called immunity booster kit manufactured by yoga guru Ramdevs Patanjali group in India, has landed in a controversy in Nepal after the Himalayan nations Department of Ayurveda and Alternative Medicine imposed a ban on its distribution.

Read More

Free Helpline
Legal Credit
Feedback